Maternal plasma inhibin A at 11-13 weeks of gestation in hypertensive disorders of pregnancy

Prenatal Diagnosis

Volumn 29, Issue 8, 2009, Pages 753-760

  Akolekar, Ranjit ^a   Minekawa, Ryoko ^a   Veduta, Alina ^a   Romero, Ximena C ^a   Nicolaides, Kypros H ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

First trimester screening; Inhibin A; Preeclampsia; Uterine artery doppler

Indexed keywords

ACETYLSALICYLIC ACID; ANTIASTHMATIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; INHIBIN A; INSULIN; THYROXINE;

ADULT; ALGORITHM; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FALSE POSITIVE RESULT; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MATERNAL PLASMA; OUTCOME ASSESSMENT; PREDICTION; PREECLAMPSIA; PRIORITY JOURNAL; PULSE WAVE; SCREENING; UTERINE ARTERY;

ADULT; ARTERIES; BLOOD FLOW VELOCITY; BLOOD PRESSURE; FEMALE; GESTATIONAL AGE; HUMANS; INHIBINS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PROSPECTIVE STUDIES; ULTRASONOGRAPHY, DOPPLER, PULSED; ULTRASONOGRAPHY, PRENATAL; UTERUS;

EID: 67749140027     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2279     Document Type: Article

References (48)

1. Aquilina J, Barnett A, Thompson O, Harrington K. 1999. Secondtrimester maternal serum inhibin A concentration as an early marker for preeclampsia. Am J Obstet Gynecol 181: 131-136. (Pubitemid 29343343)
2. Aquilina J, Thompson O, Thilaganathan B, Harriangton K. 2001. Improved early prediction of pre-eclampsia by combining second trimester maternal serum inhibin A and uterine artery Doppler. Ultrasound Obstet Gynecol 17: 477-484. (Pubitemid 32575095)
3. Ay E, Kavak ZN, Elter K, Gokaslan H, Pekin T. 2005. Screening for pre-eclampsia by using maternal serum inhibin A, activin A, human chorionic gonadotropin, unconjugated estriol, and alphafetoprotein levels and uterine artery Doppler in the second trimester of pregnancy. Aust N Z J Obstet Gynaecol 45: 283-828. (Pubitemid 41122589)
4. Bersinger NA, Sḿarason AK, Muttukrishna S, Groome NP, Redman CW. 2003. Women with preeclampsia have increased serum levels of pregnancy-associated plasma protein A (PAPP-A), inhibin A, activin A and soluble E-selectin. Hypertens Pregnancy 22: 45-55. (Pubitemid 36205807)
5. Cuckle H, Sehmi I, Jones R. 1998. Maternal serum inhibin A can predict pre-eclampsia. Br J Obstet Gynecol 105: 1101-1103. (Pubitemid 28461504)
6. D'Anna R, Baviera G, Corrado F, Leonardi I, Buemi M, Jasonni VM. 2002. Is mid-trimester maternal serum inhibin A a marker of preeclampsia or intrauterine growth restriction? Acta Obstet Gynecol Scand 81: 540-543. (Pubitemid 34628083)
7. Davey DA, MacGillivray I. 1988. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 158: 892-898. (Pubitemid 18106884)
8. Davidson EJ, Riley SC, Roberts SA, Shearing CH, Groome NP, Martin CW. 2003. Maternal serum activin, inhibin, human chorionic gonadotropin and alpha-fetoprotein as second trimester predictors of pre-eclampsia. Br J Obstet Gynecol 110: 46-52.
9. Florio P, Cobellis L, Luisi S, et al. 2001. Changes in inhibins and activin secretion in healthy and pathological pregnancies. Mol Cell Endocrinol 180: 123-130. (Pubitemid 32645637)
10. Florio P, Ciarmela P, Luisi S, et al. 2002. Pre-eclampsia with fetal growth restriction: placental and serum activin A and inhibin A levels. Gynecol Endocrinol 16: 365-372. (Pubitemid 35398650)
11. Florio P, Reis FM, Pezzani I, Luisi S, Severi FM, Petraglia F. 2003. The addition of activin A and inhibin A measurement to uterine artery Doppler velocimetry to improve the early prediction of preeclampsia. Ultrasound Obstet Gynecol 21: 165-169. (Pubitemid 36286604)
12. Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA. 2001. Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction. Hypertension 38: 718-722.
13. Gratacos E, Casals E, Gomez O, et al. 2000. Inhibin A serum levels in proteinuric and nonproteinuric pregnancy-induced hypertension: evidence for placental involvement in gestational hypertension? Hypertens pregnancy 19: 315-321. (Pubitemid 30952240)
14. Grobman WA, Wang EY. 2000. Serum levels of activin A and inhibin A and the subsequent development of preeclampsia. Obstet Gynecol 96: 390-394.
15. Hanisch CG, Pfeiffer KA, Schlebusch H, Schmolling J. 2004. Adhesion molecules, activin and inhibin-candidates for the biochemical prediction of hypertensive diseases in pregnancy? Arch Gynecol Obstet 270: 110-115. (Pubitemid 39208323)
16. Hamar BD, Buhimschi IA, Sfakianaki AK, et al. 2006. Serum and urine inhibin A but not free activin A are endocrine markers of severe pre-eclampsia. Am J Obstet Gynecol 195: 1636-1645.
17. Irgens HU, Reisaeter L, Irgens LM, Lie RT. 2001. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 323: 1213-1217. (Pubitemid 33097312)
18. Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH. 2008a. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin, and pregnancy associated plasma protein-A. Ultrasound Obstet Gynecol 31: 618-624.
19. Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH. 2008b. First trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy associated plasma protein-A: impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol 31: 493-502.
20. Kang JH, Farina A, Park JH, et al. 2008. Down syndrome biochemical markers and screening for preeclampsia at first and second trimester: correlation with the week of onset and the severity. Prenat Diagn 28: 704-709.
21. Keelan JA, Taylor R, Schellenberg JC, Groome NP, Mitchell MD, North RA. 2002. Serum activin A, inhibin A, and follistatin concentrations in preeclampsia or small for gestational age pregnancies. Obstet Gynecol 99: 267-274. (Pubitemid 34114000)
22. Khong TY, De Wolf F, Robertson WB, Brosens I. 1986. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 93: 1049-1059. (Pubitemid 16004866)
23. Kim SY, Ryu HM, Yang JH, et al. 2006. Maternal serum and amniotic fluid inhibin A levels in women who subsequently develop severe preeclampsia. J Korean Med Sci 21: 452-456. (Pubitemid 43925989)
24. Manuelpillai U, Schneider-Kolsky M, Thirunavukarasu P, Dole A, Waldron K, Wallace EM. 2003. Effect of hypoxia on placental activin A, inhibin A and follistatin synthesis. Placenta 24: 77-83. (Pubitemid 37184698)
25. McCluggage WG, Ashe P, McBride H, Maxwell P, Sloan JM. 1998. Localization of the cellular expression of inhibin in trophoblastic tissue. Histopathology 32: 252-256. (Pubitemid 28140948)
26. Muttukrishna S, Child TJ, Groome NP, Ledger WL. 1997a. Source of circulating levels of inhibin A, pro alpha C-containing inhibins and activin A in early pregnancy. Hum Reprod. 12: 1089-1093. (Pubitemid 27271776)
27. Muttukrishna S, Knight PG, Groome NP, Redman CW, Ledger WL. 1997b. Activin A and inhibin A as possible endocrine markers for preeclampsia. Lancet 349: 1285-1288. (Pubitemid 27192471)
28. Paiwattananupant K, Phupong V. 2008. Serum inhibin A level in preeclampsia and normotensive pregnancy. Hypertens pregnancy 27: 337-343.
29. Petraglia F. 1997. Inhibin, activin and follistatin in the human placenta-a new family of regulatory proteins. Placenta 18: 3-8. (Pubitemid 27105504)
30. Pijnenborg R, Anthony J, Davey DA, et al. 1991. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol 98: 648-655.
31. Plasencia W, Maiz N, Bonino S, Kaihura C, Nicolaides KH. 2007. Uterine artery Doppler at 11+0 to 13+6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 30: 742-749. (Pubitemid 47612696)
32. Poon LCY, Maiz N, Valencia C, Plasencia W, Nicolaides KH. 2009. First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia. Ultrasound Obstet Gynecol 33: 23-33.
33. R̈aty R, Koskinen P, Alanen A, Irjala K, Matinlauri I, Ekblad U. 1999. Prediction of pre-eclampsia with maternal mid-trimester total rennin, inhibin A, AFP and free β-hCG levels. Prenat Diagn 19: 122-127. (Pubitemid 29112568)
34. Redman CWG. 1991. Pre-eclampsia and the placenta. Placenta 12: 301-308.
35. Roberts JM, Redman CW. 1993. Pre-eclampsia: more than pregnancyinduced hypertension. Lancet 341: 1447-1451.
36. Sebire NJ, Roberts L, Noble P, Wallace E, Nicolaides KH. 2000. Raised maternal serum inhibin A concentration at 10-14 weeks of gestation is associated with pre-eclampsia. Br J Obstet Gynecol 107: 795-797. (Pubitemid 30311918)
37. Silver HM, Lambert-Messerlian GM, Star JA, Hogan J, Canick JA. 1999. Comparison of maternal serum total activin A and inhibin A in normal, preeclamptic, and nonproteinuric gestationally hypertensive pregnancies. Am J Obstet Gynecol 180: 1131-1137. (Pubitemid 29259006)
38. Silver HM, Lambert-Messerlian GM, Reis FM, Diblasio AM, Petraglia F, Canick JA. 2002. Mechanism of increased maternal serum total activin A and inhibin A in preeclampsia. J Soc Gynecol Investig 9: 308-312. (Pubitemid 35292300)
39. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. 1998. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 352: 343-346.
40. Spencer K, Cowans NJ, Nicolaides KH. 2008a. Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia. Ultrasound Obstet Gynecol 32: 622-626.
41. Spencer K, Cowans NJ, Nicolaides KH. 2008b. Low levels of maternal serum PAPP-A in the first trimester and the risk of preeclampsia. Prenat Diagn 28: 7-10. (Pubitemid 351251982)
42. Spencer K, Yu CK, Savvidou M, Papageorghiou AT, Nicolaides KH. 2006. Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation. Ultrasound Obstet Gynecol 27: 658-663. (Pubitemid 43967369)
43. von Dadelszen P, Magee LA, Roberts JM. 2003. Subclassification of pre-eclampsia. Hypertens Pregnancy 22: 143-148.
44. Wald NJ, Morris JK, Ibison J, Wu T, George LM. 2006. Screening in early pregnancy for pre-eclampsia using Down syndrome quadruple test markers. Prenat Diagn 26: 559-564. (Pubitemid 43989192)
45. Witlin GA, Saade GR, Mattar FM, Sibai BM. 1999. Predictors of neonatal outcome in women with severe pre-eclampsia or eclampsia between 24 and 33 weeks' gestation. Am J Obstet Gynecol 1: S19.
46. Yu CK, Smith GC, Papageorghiou AT, Cacho AM, Nicolaides KH. 2005. An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women. Am J Obstet Gynecol 193: 429-436.
47. Zeeman GG, Alexander JM, McIntire DD, Byrd W, Leveno KJ. 2002. Inhibin A levels and severity of hypertensive disorders due to pregnancy. Obstet Gynecol 100: 140-144. (Pubitemid 34722855)
48. Zwahlen M, Gerber S, Bersinger NA. 2007. First trimester markers for pre-eclampsia: placental vs non-placental protein levels. Gynecol Obstet Invest 63: 15-21. (Pubitemid 46034198)